Carole Ho
Director · Royalty Pharma plc
IndividualSelling only
- 2024
- Jun 8, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Carole Ho files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Terrance P. Coyne - $33.61M in RPRX purchases and sales in the last 12 months
- Christopher Hite - $27.36M in RPRX purchases and sales in the last 12 months
- George W. Lloyd - $9.57M in RPRX purchases and sales in the last 12 months
- Marshall Urist - $7.01M in RPRX purchases and sales in the last 12 months
- Nancy Thornberry - $262K in DNLI purchases and sales in the last 12 months
- Gregory Norden - $161K in RPRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Carole Ho?
Carole Ho is a corporate insider, tracked as Director of Royalty Pharma plc (RPRX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Carole Ho last file a Form 4?
The most recent primary Form 4 on record is dated 8 June 2026, one of 5 filings going back to 2024.
Has Carole Ho been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($52K) across all tracked filings.
